Whitehawk Therapeutics (WHWK)

• Market cap: $99M
• 1 day: -5.83%
• 5 days: 0%
• 1 month: 2.94%
• 3 months: 22.81%
• 6 months: 27.27%
• Year to date: -33.12%
• 1 year: -3.23%
• 5 years: -91.67%
• 10 years: -96.41%
• Sector: Healthcare
• Industry: Biotechnology

About: Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

Employees: 22